Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Arno Therapeutics Inc

+ Add to Watchlist

ARNI:US

0.5900 USD 0.0005 0.08%

As of 20:10:04 ET on 04/22/2015.

Snapshot for Arno Therapeutics Inc (ARNI)

Open: 0.5900 Day's Range: 0.5900 - 0.5900 Volume: 1,900
Previous Close: 0.5895 52wk Range: 0.4300 - 2.1500 1-Yr Rtn: -70.50%

Stock Chart for ARNI

No chart data available.
  • ARNI:US 0.5900
  • 1D
  • 1M
  • 1Y
0.5895
Interactive ARNI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ARNI

Current P/E Ratio (ttm) 1.9032
Estimated P/E(-) -
Relative P/E vs. SPX 0.1018
Earnings Per Share (ttm) 0.3100
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 12.04
Shares Outstanding (M) 20.41
30 Day Average Volume 4,864
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/15/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ARNI

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ARNI

Arno Therapeutics, Inc. is a development-stage company. The Company acquires, develops and commercializes products for the treatment of cancer. Arno seeks to acquire rights to novel, preclinical or early stage clinical oncology product candidates, primarily from academic and research institutions.

Alexander A Zukiwski "Alex"CEO/Chief Medical OfficerLawrence A Kenyon "Larry"CFO/COO
Stefan ProniukVP:Product DevelopmentDavid M TanenSecretary/Co-Founder
More Company Profile & Key Executives for ARNI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil